Market revenue in 2023 | USD 58.2 million |
Market revenue in 2030 | USD 75.0 million |
Growth rate | 3.7% (CAGR from 2023 to 2030) |
Largest segment | Serum separating tube |
Fastest growing segment | Coagulation Tubes |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Serum Separating Tube, Plasma Separation Tubes, EDTA Tubes, Rapid Serum Tubes, Coagulation Tubes |
Key market players worldwide | Sekisui Chemical Co Ltd, Becton Dickinson & Co, Cardinal Health Inc, Advin Health Care, AdvaCare Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vacuum blood collection tube market will help companies and investors design strategic landscapes.
Serum separating tube was the largest segment with a revenue share of 29.21% in 2023. Horizon Databook has segmented the Japan vacuum blood collection tube market based on serum separating tube, plasma separation tubes, edta tubes, rapid serum tubes, coagulation tubes covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is one of the most technologically advanced countries in Asia Pacific. Its vacuum blood collection tube market is expected to grow rapidly over the forecast period due to the high government spending to reduce the disease burden. In Japan, around 36.4 million i.e., 29.1% of the population, is aged 65 & above and the figure is expected to rise to 35.3% by 2040. The rapidly aging population and increasing expectations for improved quality of life in Japan are expected to propel market growth.
In addition, the geriatric population is more susceptible to chronic diseases and the incidence of cancer is also increasing. This is leading to an increased demand for blood tests. In recent decades, Japan’s average life expectancy has improved due to the improvements in environmental sanitation and medical care.
However, with a notable rate of thyroid disorders in Japan, blood tests for thyroid function are common, and it supports the market for blood collection devices. Approximately 2.4 million patients in Japan need treatment for thyroid disease. However, only 450,000 of them are receiving treatment in 2021.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan vacuum blood collection tube market , including forecasts for subscribers. This country databook contains high-level insights into Japan vacuum blood collection tube market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account